Story perspectives

Gene Therapy Market Set to Surge to $52 Billion by 2035

9/22/2025

50 9

Summary

Story summary

The Advanced Therapy Based on Gene Market is set to grow from USD 11.9 billion in 2024 to USD 52.0 billion by 2035, driven by technological advancements and increasing genetic disorders.
Key applications include oncology, neurology, and infectious diseases, utilizing gene editing and cell therapy.
North America leads the market, followed by Europe and APAC, due to strong R&D investment.
Major players like Novartis, CRISPR Therapeutics, and Gilead Sciences focus on strategic partnerships and R&D.
The CRISPR market is projected to reach USD 27.5 billion by 2035, despite regulatory challenges.

1 of 1

Story summary

The Advanced Therapy Based on Gene Market is set to grow from USD 11.9 billion in 2024 to USD 52.0 billion by 2035, driven by technological advancements and increasing genetic disorders.
Key applications include oncology, neurology, and infectious diseases, utilizing gene editing and cell therapy.
North America leads the market, followed by Europe and APAC, due to strong R&D investment.
Major players like Novartis, CRISPR Therapeutics, and Gilead Sciences focus on strategic partnerships and R&D.
The CRISPR market is projected to reach USD 27.5 billion by 2035, despite regulatory challenges.